scispace - formally typeset
P

Pierre-Emmanuel Rautou

Researcher at University of Paris

Publications -  241
Citations -  15343

Pierre-Emmanuel Rautou is an academic researcher from University of Paris. The author has contributed to research in topics: Cirrhosis & Portal hypertension. The author has an hindex of 47, co-authored 197 publications receiving 12321 citations. Previous affiliations of Pierre-Emmanuel Rautou include Paris Descartes University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Liver sinusoidal endothelial cells: Physiology and role in liver diseases.

TL;DR: This review provides an overview of the strategies available for a specific targeting of LSECs and presents a detailed analysis of the technical aspects relevant for LSEC analysis including the markers these cells express, the available cell lines and the transgenic mouse models.
Journal ArticleDOI

Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

TL;DR: The use of beta‐blockers is associated with poor survival in patients with refractory ascites, and results suggest that beta‐ blockers should be contraindicated in these patients.
Journal ArticleDOI

Autophagy in liver diseases

TL;DR: In liver ischemia reperfusion injury, autophagy mainly has a prosurvival activity allowing the cell for coping with nutrient starvation and anoxia, and in α-1-antitrypsin deficiency, the aggregation-prone ATZ protein accumulates in the endoplasmic reticulum and activates the autophagic response which aims at degrading mutant ATZ.
Journal ArticleDOI

Extracellular vesicles in coronary artery disease

TL;DR: Current knowledge on the role of extracellular vesicles in coronary artery disease, and their emerging potential as biomarkers and therapeutic agents are summarized.